Literature DB >> 15567546

Neurological complications in renal failure: a review.

R Brouns1, P P De Deyn.   

Abstract

Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic advances, many neurological complications of uremia, like uremic encephalopathy, atherosclerosis, neuropathy and myopathy fail to fully respond to dialysis. Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis can directly or indirectly be associated with dialysis dementia, dysequilibrium syndrome, aggravation of atherosclerosis, cerebrovascular accidents due to ultrafiltration-related arterial hypotension, hypertensive encephalopathy, Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and mononeuropathy. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease. The use of immunosuppressive drugs after renal transplantation can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. We address the clinical, pathophysiological and therapeutical aspects of both central and peripheral nervous system complications in uremia.

Entities:  

Mesh:

Year:  2004        PMID: 15567546     DOI: 10.1016/j.clineuro.2004.07.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  95 in total

1.  47-year-old woman with dizziness, weakness, and confusion.

Authors:  Rozalina Grubina; David L Klocke
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

2.  Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia.

Authors:  Mustafa Gokce; Ekrem Dogan; Saadet Nacitarhan; Gulen Demirpolat
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  Surgical sepsis and organ crosstalk: the role of the kidney.

Authors:  Laura E White; Rahul Chaudhary; Laura J Moore; Frederick A Moore; Heitham T Hassoun
Journal:  J Surg Res       Date:  2010-12-30       Impact factor: 2.192

4.  An unexpected abnormality on the EEG.

Authors:  Clodagh M Ryan; Brian J Murray
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

5.  Psychomotor functions at various weeks of chronic renal failure in rats.

Authors:  Merin Iype Chandanathil; Subramanya Upadhya; Sharmila Upadhya; Gopalakrishna Bhat
Journal:  Cogn Neurodyn       Date:  2014-10-28       Impact factor: 5.082

6.  Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.

Authors:  Chao Chai; Mengjie Zhang; Miaomiao Long; Zhiqiang Chu; Tong Wang; Lijun Wang; Yu Guo; Shuo Yan; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2015-03-22       Impact factor: 3.584

7.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 8.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

9.  Pancytopenia associated with clonazepam.

Authors:  Marnelli A Bautista-Quach; Yu-Min Liao; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-07-14       Impact factor: 17.388

Review 10.  Organ cross talk and remote organ damage following acute kidney injury.

Authors:  Rele Ologunde; Hailin Zhao; Kaizhi Lu; Daqing Ma
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.